Results 81 to 90 of about 22,551 (179)
International Journal of Dermatology, Volume 63, Issue 12, Page 1755-1760, December 2024.Abstract Background Pediatric pemphigus is a rare bullous disease that represents a diagnostic and therapeutic challenge; evidence on patients' response to various treatments and long‐term surveillance data are lacking. We aimed to investigate pediatric pemphigus patients' characteristics, diagnosis, therapeutics, response, and long‐term follow‐up ...
Yael Renert‐Yuval +6 more
wiley +1 more source
Epidermolysis bullosa acquisita
, 1988 A case of epidermolysis bullosa acquisita (EBA) occurring in a 30 year-old-farmer is described. Diagnosis was suggested by clinical signs (adult-onset of mechano-bullous lesions healing with atrophic scar and milia formation, in absence of family history,
PISANI M +2 more
core
Epidermolysis Bullosa Acquisita: Ultrastructural and Immunological Studies [PDF]
, 1981 Four patients with epidermolysis bullosa acquisita were investigated using immunofluorescence, routine electron microscopic and immunoelectron microscopic techniques. Immunofluorescence studies demonstrated linear immunoglobulin and complement deposition
Katz, Stephen +9 more
core +1 more source
A Mouse Monoclonal Antibody Against a Newly Discovered Basement Membrane Component, the Epidermolysis Bullosa Acquisita Antigen [PDF]
, 1985 A mouse monoclonal antibody, H3a, directed against the newly described epidermolysis bullosa acquisita (EBA) antigen was obtained using hybridoma techniques.
O'Keefe, Edward +5 more
core +1 more source
Epidermolysis bullosa acquisita with moderately severe dysphagia due to esophageal strictures
Indian Journal of Dermatology, 2011 Epidermolysis bullosa acquisita (EBA) is a chronic, autoimmune condition involving the skin and mucous membranes. Symptomatic mucosal involvement is rare, but can impact on quality of life, due to esophageal strictures and dysphagia.
Jenny Tu, Prasad W Kumarasinghe
doaj +1 more source
Epidermolysis bullosa acquisita associated with epidermal-binding circulating antibodies.
, 2016 Epidermolysis bullosa acquisita (EBA) is a rare, immunobullous disease, characterized by circulating and tissue-bound antibodies against type VII collagen (C7) of anchoring fibrils in the cutaneous basement membrane zone. These antibodies localize to the
core +1 more source
Frontiers in Immunology, 2018 Epidermolysis bullosa acquisita (EBA) is an antibody-mediated blistering skin disease associated with tissue-bound and circulating autoantibodies to type VII collagen (COL7).
Sidonia Mihai +11 more
doaj +1 more source
Urticarial Plaques With Vesicles in a Young Hispanic Woman
JEADV Clinical Practice, Volume 4, Issue 4, Page 946-949, September 2025.
Valeria Olvera‐Rodríguez +6 more
wiley +1 more source
PDE4 Inhibition as Potential Treatment of Epidermolysis Bullosa Acquisita [PDF]
, 2016 Pemphigoid diseases such as epidermolysis bullosa acquisita (EBA) may be difficult to treat. In pemphigoid diseases, mucocutaneous blistering is caused by autoantibodies to hemidesmosomal antigens; in EBA the autoantigen is type VII collagen.
Tenor, Hermann +10 more
core +1 more source
Scarring Alopecia in a 66‐Year‐Old Woman
JEADV Clinical Practice, Volume 4, Issue 2, Page 624-626, June 2025.
Sergio Castillo Pinto +2 more
wiley +1 more source